Brainsway Common Stock Net 2018-2025 | BWAY
Brainsway common stock net from 2018 to 2025. Common stock net can be defined as the value of common equity ownership.
| Brainsway Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| Brainsway Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.221B | $0.041B |
| BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.138B | 26.52 |
| Boston Scientific (BSX) | United States | $158.236B | 37.74 |
| Stryker (SYK) | United States | $145.846B | 29.69 |
| EssilorLuxottica (ESLOY) | France | $137.406B | 0.00 |
| Medtronic (MDT) | Ireland | $114.967B | 16.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.252B | 0.00 |
| ResMed (RMD) | United States | $42.733B | 30.52 |
| Haleon (HLN) | United Kingdom | $42.722B | 24.39 |
| Agilent Technologies (A) | United States | $32.622B | 21.27 |
| GE HealthCare Technologies (GEHC) | United States | $32.252B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $25.729B | 17.02 |
| Terumo (TRUMY) | Japan | $25.658B | 33.33 |
| Insulet (PODD) | United States | $20.252B | 79.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.281B | 11.74 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.485B | 0.00 |
| Baxter (BAX) | United States | $11.516B | 8.90 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.532B | 27.51 |
| Lantheus Holdings (LNTH) | United States | $4.944B | 12.47 |
| Perrigo (PRGO) | Ireland | $3.706B | 9.39 |
| Prestige Consumer Healthcare (PBH) | United States | $3.667B | 16.38 |
| Haemonetics (HAE) | United States | $3.666B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.403B | 23.81 |
| ICU Medical (ICUI) | United States | $3.201B | 23.60 |
| LeMaitre Vascular (LMAT) | United States | $1.906B | 42.61 |
| AtriCure (ATRC) | United States | $1.807B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.630B | 11.21 |
| Green Thumb Industries (GTBIF) | United States | $1.543B | 34.71 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.229B | 12.48 |
| Curaleaf Holdings (CURLF) | Canada | $1.106B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.100B | 14.06 |
| Neogen (NEOG) | United States | $1.017B | 16.14 |
| BioLife Solutions (BLFS) | United States | $0.999B | 0.00 |
| InMode (INMD) | Israel | $0.889B | 8.23 |
| Kestra Medical Technologies (KMTS) | United States | $0.795B | 0.00 |
| Valneva SE (VALN) | France | $0.638B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.612B | 0.00 |
| Evolus (EOLS) | United States | $0.587B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.578B | 0.00 |
| CeriBell (CBLL) | United States | $0.550B | 0.00 |
| Owens & Minor (OMI) | United States | $0.533B | 4.42 |
| ZimVie (ZIMV) | United States | $0.529B | 20.40 |
| Surmodics (SRDX) | United States | $0.509B | 0.00 |
| SNDL (SNDL) | Canada | $0.431B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.344B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.293B | 10.77 |
| Aurora Cannabis (ACB) | Canada | $0.260B | 77.00 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.247B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.240B | 20.23 |
| OraSure Technologies (OSUR) | United States | $0.233B | 0.00 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| Biote (BTMD) | United States | $0.226B | 6.35 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.220B | 0.00 |
| Exagen (XGN) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.18 |
| Vireo Growth (VREOF) | United States | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.159B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.144B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.09 |
| Safety Shot (SHOT) | United States | $0.116B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.105B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.29 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.070B | 0.00 |
| Apyx Medical (APYX) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Zynex (ZYXI) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.80 |
| Nephros (NEPH) | United States | $0.034B | 46.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Senestech (SNES) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |